Molecular genetic findings in prader-willi syndrome

Management of Prader-Willi Syndrome: Third Edition

Volumn , Issue , 2006, Pages 58-73

  Buiting, Karin ^a   Horsthemke, Bernhard ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 41849085475     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-33536-0_3     Document Type: Chapter

References (77)

1. Amos-Landgraf JM, Ji Y, Gottlieb W, et al. Chromosome breakage in the Prader-Willi and Angelman syndromes involves recombination between large, transcribed repeats at proximal and distal breakpoints. American Journal of Human Genetics. 1999;65:370-386.
2. Bielinska B, Blaydes SM, Buiting K, et al. De novo deletions of the SNRPN exon 1 region in early human and mouse embryos result in a paternal to maternal imprint switch. Nature Genetics. 2000;25:74-78.
3. Bittel DC, Kibiryeva N, Talebizadeh Z, Butler MG. Microarray analysis of gene/transcript expression in Prader-Willi syndrome: deletion versus UPD. Journal of Medical Genetics. 2003;40:568-574.
4. Bittel DC, Kibiryeva N, Talebizadeh Z, Driscoll DJ, Butler MG. Microarray analysis of gene/transcript expression in Angelman syndrome: deletion versus UPD. Genomics. 2005;85:85-91.
5. Boccaccio I, Glatt-Deeley H, Watrin F, Roeckel N, Lalande M, Muscatelli F. The human MAGEL2 gene and its mouse homologue are paternally expressed and mapped to the Prader-Willi region. Human Molecular Genetics. 1999;8:2497-2505.
6. Brannan CI, Chamberlain S. Mouse models of Prader-Willi syndrome. 2001 International Prader-Willi Syndrome Scientific Conference, St. Paul, MN, USA.
7. Bressler J, Tsai TF, Wu MY, et al. The SNRPN promoter is not required for genomic imprinting of the Prader-Willi/Angelman domain in mice. Nature Genetics. 2001;28:232-240.
8. Buiting K, Dittrich B, Endele S, Horsthemke B. Identification of novel exons 3' of the human SNRPN gene. Genomics. 1997;40:132-137.
9. Buiting K, Dittrich B, Groß S, et al. Sporadic imprinting defects in Prader-Willi syndrome and Angelman syndrome: implications for imprint-switch models, genetic counseling, and prenatal diagnosis. American Journal of Human Genetics. 1998;63:170-180.
10. Buiting K, Färber C, Kroisel P, et al. Imprinting centre deletions in two PWS families: implications for diagnostic testing and genetic counseling. Clinical Genetics. 2000;58:284-290.
11. Buiting K, Greger V, Brownstein BH, et al. A putative gene family in 15q11-13 and 16p11.2: possible implications for Prader-Willi and Angelman syndromes. Proceedings of the National Academy of Science USA. 1992;89:5457-5461.
12. Buiting K, Groß S, Ji Y, Senger G, Nicholls RD, Horsthemke B. Expressed copies of the MN7 (D15S37) gene family map close to the common deletion breakpoints in the Prader-Willi/Angelman syndromes. Cytogenetics and Cell Genetics. 1998;81:247-253.
13. Buiting K, Groß S, Lich C, Gillessen-Kaesbach G, El-Maarri O, Horsthemke B. Epimutations in Prader-Willi and Angelman syndrome: a molecular study of 136 patients with an imprinting defect. American Journal of Human Genetics. 2003;72:571-577.
14. Buiting K, Lich C, Cottrell S, Barnicoat A, Horsthemke B. A 5-kb imprinting center deletion in a family with Angelman syndrome reduces the shortest region of deletion overlap to 880 bp. Human Genetic. 1999;105:665-666.
15. Buiting K, Saitoh S, Groß S, et al. Inherited microdeletions in the Angelman and Prader-Willi syndromes define an imprinting center on human chromosome
16. Nature Genetics. 1995;9:395-400.
17. Bürger J, Horn D, Tonnies H, Neitzel H, Reis A. Familial interstitial 570 kbp deletion of the UBE3A gene region causing Angelman syndrome but not Prader-Willi syndrome. American Journal of Medical Genetics. 2002;111:233-237.
18. Butler MG. Prader-Willi syndrome: current understanding of cause and diagnosis. American Journal of Medical Genetics. 1990;35:319-332.
19. Butler MG, Bittel DC, Kibiryeva N, Talebizadeh Z, Thompson T. Behavioral differences among subjects with Prader-Willi syndrome and type I or type II deletion and maternal disomy. Pediatrics. 2004;113:565-573.
20. Butler MG, Palmer CG. Parental origin of chromosome 15 deletion in Prader-Willi syndrome. Lancet. 1983;1:1285-1286.
21. Carrozzo R, Rossi E, Christian SL, et al. Inter-and intrachromosomal rearrangements are both involved in the origin of 15q11-q13 deletions in Prader-Willi syndrome. American Journal of Human Genetics. 1997;61:228-230.
22. Cattanach BM, Barr JA, Evans EP, et al. A candidate mouse model for Prader-Willi syndrome which shows an absence of SNRPN expression. Nature Genetics. 1992;2:270-274.
23. Cavaillé J, Buiting K, Kiefmann M, et al. Identification of brain-specific and imprinted small nucleolar RNA genes exhibiting an unusual genomic organization. Proceedings of the National Academy of Science USA. 2000;7:14311-14316.
24. Chai JH, Locke DP, Greally JM, et al. Identification of four highly conserved genes between breakpoint hotspots BP1 and BP2 of the Prader-Willi/Angelman syndromes deletion region that have undergone evolutionary transposition mediated by flanking duplicons. American Journal of Human Genetics. 2003;73:898-925.
25. Chamberlain SJ, Johnstone KA, DuBose AJ, et al. Evidence for genetic modifiers of postnatal lethality in PWS-IC deletion mice. Human Molecular Genetics. 2004;13(23):2971-2977.
26. Christian SL, Fantes JA, Mewborn SK, Huang B, Ledbetter DH. Large genomic duplicons map to sites of instability in the Prader-Willi/Angelman syndrome chromosome region (15q11-q13). Human Molecular Genetics. 1999;8:1025-1037.
27. Christian SL, Robinson WP, Huang B. et al. Molecular characterization of two proximal deletion breakpoint regions in both Prader-Willi and Angelman syndrome patients. American Journal of Human Genetics. 1995;57:40-48.
28. Crolla JA, Harvey JF, Slitch LF, Dennis NR. Supernumerary marker 15 chromosomes: a clinical, molecular and FISH approach to diagnosis and prognosis. Human Genetics. 1995;95:161-170.
29. Conroy JM, Grebe TA, Becker LA, et al. Balanced translocation 46, XY, t (2;15) (q37.2;q11.2) associated with atypical Prader-Willi syndrome. American Journal of Human Genetics. 1997;61:388-394.
30. Dittrich B, Buiting K, Korn B, et al. Imprint switching on human chromosome 15 may involve alternative transcripts of the SNRPN gene. Nature Genetics. 1996;14:163-170.
31. El-Maarri O, Buiting K, Peery EG. Maternal methylation imprints on human chromosome 15 are established during or after fertilization. Nature Genetics. 2001;27:341-344.
32. Färber C, Dittrich B, Buiting K, Horsthemke B. The chromosome 15 imprinting centre (IC) region has undergone multiple duplication events and contains an upstream exon of SNRPN that is deleted in all Angelman syndrome patients with an IC microdeletion. Human Molecular Genetics. 1999;8:337-343.
33. Gabriel J, Merchant M, Ohta T, et al. A transgene insertion creating a heritable chromosome deletion mouse model of Prader-Willi and Angelman syndromes. Proceedings of the National Academy of Sciences USA. 1999;96:9258-9263.
34. Gerard M, Hernandez L, Wevrick R, Stewart CL. Disruption of the mouse Necdin gene results in early post-natal lethality. Nature Genetics. 1999;23:199-202.
35. Gray TA, Saitoh S, Nicholls RD. An imprinted, mammalian bicistronic transcript encodes two independent proteins. Proceedings of the National Academy of Sciences USA. 1999;96:5616-5621.
36. Hamabe J, Kuroki Y, Imaizumi K, et al. DNA deletion and its parental origin in Angelman syndrome patients. American Journal of Medical Genetics. 1991;41(1):64-68.
37. Herzing LB, Kim SJ, Cook EH, Ledbetter DH. The human aminophospholipidtransporting ATPase gene ATP10C maps adjacent to UBE3A and exhibits similar imprinted expression. American Journal of Human Genetics. 2001;68:1501-1505.
38. Horsthemke B, Nazlican H, Hüsing J, et al. Somatic mosaicism for maternal uniparental disomy 15 in a girl with Prader-Willi syndrome: confirmation by cell cloning and identification of candidate downstream genes. Human Molecular Genetics. 2003;12:2723-2732.
39. Jay P, Rougeulle C, Massacrier A, et al. The human necdin gene, NDN, is maternally imprinted and located in the Prader-Willi syndrome chromosomal region. Nature Genetics. 1997;17:357-361.
40. Ji Y, Walkowicz M, Buiting K, et al. The ancestral gene for transcribed, lowcopy repeats in the Prader-Willi/Angelman region encodes a large protein implicated in protein trafficking that is deficient in mice with neuromuscular and spermiogenic abnormalities. Human Molecular Genetics. 1999;8:533-542.
41. Jong M T C, Gray TA, Ji Y, et al. A novel imprinted gene, encoding a RING zinc-finger protein, and overlapping antisense transcript in the Prader-Willi syndrome critical region. Human Molecular Genetics. 1999;8:783-793.
42. Kishino T, Lalande M, Wagstaff J. UBE3A/E6-AP mutations cause Angelman syndrome. Nature Genetics. 1997;15:70-73.
43. Knoll JH, Nicholls RD, Magenis RE, Glatt K. Angelman syndrome: Three molecular classes identified with chromosome 15q11q13-specific DNA markers. American Journal of Human Genetics. 1990;47:149-155.
44. Knoll J H M, Nicholls RD, Magenis RE, Graham JM Jr, Lalande M, Latt SA. Angelman and Prader-Willi syndromes share a common chromosome 15 deletion but differ in parental origin of the deletion. American Journal of Medical Genetics. 1989;32:285-290.
45. Kuwano A, Mutirangura A, Dittrich B, et al. Molecular dissection of the Prader-Willi/Angelman syndrome region (15q11-13) by YAC cloning and FISH analysis. Human Molecular Genetics. 1992;1:417-425.
46. Ledbetter DH, Riccardi VM, Airhart SD, Strobel RJ, Keenan SB, Crawford JD. Deletions of chromosome 15 as a cause of the Prader-Willi syndrome. New England Journal of Medicine. 1981;304:325-329.
47. Lee S, Kozlov S, Hernandez L, et al. Expression and imprinting of MAGEL2 suggest a role in Prader-Willi syndrome and the homologous murine imprinting phenotype. Human Molecular Genetics. 2000;9:1813-1819.
48. MacDonald H, Wevrick, R. The necdin gene is deleted in Prader-Willi syndrome and is imprinted in human and mouse. Human Molecular Genetics. 1997;11:1873-1878.
49. Matsuura T, Sutcliffe JS, Fang P, et al. De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nature Genetics. 1997;5:74-77.
50. Meguro M, Kashiwagi A, Mitsuya K, et al. A novel maternally expressed gene, ATP10C encodes a putative aminophospholipid translocase associated with Angelman syndrome. Nature Genetics. 2001;28:19-20.
51. Muscatelli F, Abrous DN, Massacrier A, et al. Disruption of the mouse Necdin gene results in hypothalamic and behavioral alteration reminiscent of the human Prader-Willi syndrome. Human Molecular Genetics. 2000;9:3101-3110.
52. Mutirangura A, Jayakumar A, Sutcliffe JS, et al. A complete YAC contig of the Prader-Willi/Angelman chromosome region (15q11-q13) and refined localization of the SNRPN gene. Genomics. 1993;18:546-552.
53. Nicholls RD, Knoll JH, Butler MG, Karam S, Lalande M. Genetic imprinting suggested by maternal uniparental heterodisomy in nondeletion Prader-Willi syndrome. Nature. 1989;342:281-285.
54. Özcelik T, Leff S, Robinson W, et al. Small nuclear ribonucleoprotein polypeptide N (SNRPN), an expressed gene in the Prader-Willi syndrome critical region. Nature Genetics. 1992;2:265-269.
55. Ohta T, Gray TA, Rogan PK, et al. Imprinting-mutation mechanisms in Prader-Willi syndrome. American Journal of Human Genetics. 1999;64:397-413.
56. Rainier S, Chai JH, Tokarz D, Nicholls RD, Fink JK. NIPA1 Gene mutations cause autosomal dominant hereditary spastic paraplegia (SPG6). American Journal of Human Genetics. 2003;73:967-971.
57. Ren J, Lee S, Pagliardini S, et al. Absence of Ndn, encoding the Prader-Willi syndrome-deleted gene necdin, results in congenital deficiency of central respiratory drive in neonatal mice. Journal of Neuroscience. 2003;23:1569-1573.
58. Robinson WP, Dutly F, Nicholls RD, et al. The mechanisms involved in formation of deletions and duplications of 15q11-q13. Journal of Medical Genetics. 1998;35:130-136.
59. Robinson WP, Spiegel R, Schinzel AA. Deletion breakpoints associated with the Prader-Willi and Angelman syndromes (15q11-q13) are not sites of high homologous recombination. Human Genetics. 1993;91:181-184.
60. Runte M, Hüttenhofer A, Groß S, Kiefmann M, Horsthemke B, Buiting K. The IC-SNURF-SNRPN transcript serves as a host for multiple small nucleolar RNA species and as an antisense RNA for UBE3A. Human Molecular Genetics. 2001;10:2687-2700.
61. Saitoh S, Buiting K, Rogan PK, et al. Minimal definition of the imprinting center and fixation of a chromosome 15q11-q13 epigenotype by imprinting mutations. Proceedings of the National Academy of Science USA. 1996;93:7811-7815.
62. Saria A, Troger J, Kirchmair R, Fischer-Colbrie R, Hogue-Angeletti R, Winkler H. Secretoneurin releases dopamine from rat striatal slices: a biological effect of a peptide derived from secretograninII (chromograninC). Neuroscience. 1993;54:1-4.
63. Schinzel AA, Brecevic L, Bernasconi F, et al. Intrachromosomal triplication of 15q11-q13. Journal of Medical Genetics. 1994;31:798-803.
64. Schulze A, Hansen C, Skakkebaek NE, Brondum-Nielsen K, Ledbetter DH, Tommerup N. Exclusion of SNRPN as a major determinant of Prader-Willi syndrome by a translocation breakpoint. Nature Genetics. 1996;12(4):452-454.
65. Spritz RA, Bailin T, Nicholls RD, et al. Hypopigmentation in the Prader-Willi syndrome correlates with P gene deletion but not with haplotype of the hemizygous P allele. American Journal of Medical Genetics. 1997;71:57-62.
66. Sutcliffe JS, Nakao M, Christian S, et al. Deletions of a differentially methylated CpG island at the SNRPN gene define a putative imprinting control region. Nature Genetics. 1994;8:52-58.
67. Sun Y, Nicholls RD, Butler MG, Saitoh S, Hainline BE, Palmer CG. Breakage in the SNRPN locus in a balanced 46, XY, t (15;19) Prader-Willi syndrome patient. Human Molecular Genetics. 1996;5:517-524.
68. Tsai TF, Armstrong D, Beaudet AL. Necdin-deficient mice do not show lethality or the obesity and infertility of Prader-Willi syndrome. Nature Genetics. 1999;22:15-16.
69. Tsai TF, Jiang Y, Bressler J, Armstrong D, Beaudet AL. Paternal deletion from Snrpn to Ube3a in the mouse causes hypotonia, growth retardation and partial lethality and provides evidence for a gene contributing to Prader-Willi syndrome. Human Molecular Genetics. 1999;8:1357-1364.
70. Wang GJ, Volkow ND, Logan J, et al. Brain dopamine and obesity. Lancet. 2001;357:354-357.
71. Webb T. Inv dup (15) supernumerary marker chromosomes. Journal of Medical Genetics. 1994;31:585-594.
72. Wevrick R, Kerns JA, Francke U. Identification of a novel paternally expressed gene in the Prader-Willi syndrome region. Human Molecular Genetics. 1994;3:1877-1882.
73. White RA, Vorontosova E, Chen R, et al. A behavioral and correlated neurochemical mouse phenotype related to the absence of Snrpn, a locus associated with Prader-Willi syndrome. American Journal of Human Genetics Supplement. 2002;71:467.
74. Wirth J, Back E, Hüttenhofer A, et al. A translocation breakpoint cluster disrupts the newly defined 3' end of the SNURF-SNRPN transcription unit on chromosome 15. Human Molecular Genetics. 2001;10:201-210.
75. Volkow ND, Wang GJ, Fowler JS, et al. "Nonhedonic" food motivation in humans involves dopamine in the dorsal striatum and methylphenidate amplifies this effect. Synapse. 2002;44:175-180.
76. Volkow ND, Wang GJ, Maynard L, et al. Brain dopamine is associated with eating behaviors in humans. International Journal for Eating Disorders. 2003;33:136-142.
77. Yang T, Adamson TE, Resnick JL, et al. A mouse model for Prader-Willi syndrome imprinting-centre mutations. Nature Genetics. 1998;19:25-31.